Taj Worldwide | Taj Group | Media | Career | FAQs | Feedback | contact us
Taj Logo
Quality Medicines API Generic Manufacturing For Doctors Brands Newsroom

manufacturing quality




With our world class technology, we work with built systems that meet the most stringent international manufacturing standards. Expert quality teams ensure that systems and processes remain in compliance with the latest standards and international markets.

Our plants hold approvals from the FDA and compliment regulatory authorities.

 Pharmaceuticals Manufacturing Plants / Units   Manufacturing Details  /Capacity
 Tablet and Capsule Plant / Unit  Pharmaceuticals Manufacturing
 API Plant / Unit  API Manufacturing
 Chemical Plant / Unit  Chemical Manufacturing
 Soft Gelatin Unit / Plant  Soft Gelatin Manufacturing
 Agro Plant / Unit  Agro Manufacturing

Manufacturing Plants / Units

Virtual Tour of Plants


We make specialty formulations across a range of dosage forms- oral, injectable and delivery system based.

active pharma ingredientsAPI

We make specialty API’s including peptides, steroids, hormones and anticancer at internationally approved world-class sites.

quality policyQuality Policy

Regularly updated systems, procedures and an expert team support a stringent quality policy.

Our facilities has been approved by WHO-GMP and several international regulators across the semi-regulated markets. It caters to the bulk of the demand for solid orals, liquid orals, and external creams and powders across markets in Asia, Africa, Middle East, Russia and Latin America.

The company is presently expanding this facility and building a dedicated export oriented unit to cater to growth in demand for its exclusive generics (4600), solid orals, semi-solid and liquid orals range of formulations in semi-regulated markets.

Test Equipment and Facilities : The manufacturing facilities are based in Mehsana, (Gujarat), Baroda, Sarigam (Daman and Diu) and Raigad (Puna Expressway, Maharashtra) and operated by Taj Pharmaceuticals Ltd.

In our quest to be the leading manufacturer in the pharmaceutical industry and a Genericsfda player of global standing; we aspire to meet and excel the highest industry standards. To this end, on the manufacturing front, we have designed and engineered our production facilities to the most rigorous benchmarks and according to the guidelines of world health organisation.

We operate with modern fda facility for the production of sterile powder formulations, non-sterile oral formulations and active pharmaceutical ingredients.

Some other features of our facility:
* Modern QA, QC, Microbiological and PD Lab supported with high-tech equipment.

* Fully automated with electronically controlled operating system as per Good Automated Manufacturing Practice guidelines.

* Sophisticated Effluent Treatment Plant (ETP) with a capacity of 100,000 liters per day.

* Conforms to international environmental, health & safety regulations

Our facility consistently meets and exceeds our own stringent quality assurance standards, administered by an Internal Quality Assurance team reporting directly to the Managing Director, as well as those imposed by regulatory bodies. IQ /OQ / PQ validations have been completed on all equipment to which these apply.

In addition, we are a registered drug manufacturing facility with an impressive inspection record. All our manufacturing sites are WHO-GMP approved.

Our expertise APIs (CTD & formulation dossiers) will help us further enhance our own product range as well as the size and diversity of our toll / contract manufacturing business segment.

Modern methods like aqueous coating, tablet packing in combi-packs etc., are implemented in the manufacturing process.

The Hyderabad plant is the ONLY plant in the world producing all the effective ranges of Anti-tuberculosis formulations namely Ethambutol Hydrochloride (B.P.), Rifampicin (B.P.), Isoniazid (B.P.), Pyrazinamide (B.P.), Rifampicin-Isoniazid (B.P.), Rifampicin-Isoniazid-Pyrazinamide (B.P.), Ethionamide (B.P.) and Prothionamide (B.P.) - all in Tablet form. Production of bulk actives such as Ethambutol, Rifampicin and Pyrazinamide are also undertaken at Valsad, Gujrat (India).

R & D activity is a continuous on-going process and the R & D Division at all Units and has been duly approved by the Department of Scientific and Industrial Research, (DSIR), Government of India.

The API Plant, which is involved in Fermentation activity has been suitably up-graded and manufactures products like - Lovastatin, Simvastatin, DMCTC, Gentamycin, Sisomycin, etc., The Plant also exclusively manufactures a veterinary product range for a foreign multinational, - in addition Taj Pharma India is one of the few suppliers of this product in the market.

on www.tajpharma.com


"Our vision is to be a leading pharmaceutical company in India and to become a significant global player by providing high quality, affordable and innovative solutions in medicine and treatment. "


"We will discover, develop and successfully market pharmaceutical products to prevent, diagnose, alleviate and cure diseases”.

We shall provide total customer satisfaction and achieve leadership in chosen markets, products and services across the globe, through excellence in technology, based on world-class research and development.
Know more about Manufacturing :

Pharmaceuticals Products | Diseases | Generic Index | Taj Generic | API | Manufacturing
Pharmacological Index
| Generic Medicines | PDF Download | DOC Download
           Brochures Download | API Manufacturing |
Virtual Tour of Plants


generic medicines


capsules in hand




 Print page   Send by mail


  india flag
  The Taj Pharmaceuticals Limited (Taj Group) has operations in every major international market










Vacancies | C & F Agency | Distributor | Group Companies | History | Enquire Form | Countries | Pharma Technology
 Contact | Sitemap | User Terms and Conditions | Privacy and Cookie Statement